Advances in genomics, data science, machine learning, and artificial intelligence are transforming practice. Next generation public health and medical workforces need to understand these developm...
Two recent studies document ongoing underutilization and disparities in genetic testing for patients with breast and ovarian cancer. BRCA1 and BRCA2 (BRCA) genetic testing is supported by clinica...
https://blogs.cdc.gov/genomics/2023/07/25/persistent-underutilization/
It is estimated that 3 million people in the United States carry pathogenic variants that increase their risks for heart disease and cancer. If people with such variants are identified, medical i...
In the more than 20 years since the completion of the Human Genome Project, basic and clinical research have delivered on the promise to develop genomic applications that can help prevent and tre...
Population genomic screening of adults has emerged as a strategy to promote prevention of common diseases such as cancer and heart disease among persons with genetic conditions. This type of scre...
https://blogs.cdc.gov/genomics/2023/06/20/population-based-genomic/
Successful implementation of evidence-based genomic and precision health interventions requires an understanding of what works and what doesn’t work within the context of various clinical and p...
https://blogs.cdc.gov/genomics/2023/06/16/tracking-the-contributions/
A recent systematic review that assessed the cost-effectiveness of pharmacogenetic testing for drugs with existing guidelines concluded that most studies favored pharmacogenomic testing. The sign...
https://blogs.cdc.gov/genomics/2023/05/08/cost-effectiveness/
The All of Us Reports and Publications Database (AofURPD) is a continuously updated, searchable database referencing and linking to peer reviewed journal publications, preprint records, as well a...
https://blogs.cdc.gov/genomics/2023/03/28/tracking-the-impact/
In this post, we explore how new research on rare genetic diseases is contributing to our understanding of COVID-19 occurrence and outcomes and discuss potential clinical and public health implic...
https://blogs.cdc.gov/genomics/2023/03/27/rare-primary-immunodeficiency/
A recent article discusses the promise of precision medicine research for cancer prevention and control in the National Institutes of Health (NIH)’s All of Us research program. In 2015, then-Pr...
https://blogs.cdc.gov/genomics/2023/02/27/a-piece-of-a-puzzle/